BPI
Basic information
Region (hg38): 20:38260141-38337505
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
- not_specified (58 variants)
- not_provided (11 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the BPI gene is commonly pathogenic or not. These statistics are base on transcript: NM_000001725.3. Only rare variants are included in the table.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUSVUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 4 | |||||
| missense | 53 | 63 | ||||
| nonsense | 0 | |||||
| start loss | 0 | |||||
| frameshift | 0 | |||||
| splice donor/acceptor (+/-2bp) | 0 | |||||
| Total | 0 | 0 | 53 | 9 | 5 |
GnomAD
Source:
| Gene | Type | Bio Type | Transcript | Coding Exons | Length |
|---|---|---|---|---|---|
| BPI | protein_coding | protein_coding | ENST00000262865 | 15 | 77357 |
| pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
|---|---|---|---|---|---|---|
| 1.65e-14 | 0.0518 | 125587 | 0 | 161 | 125748 | 0.000640 |
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
|---|---|---|---|---|---|---|
| Missense | -0.780 | 322 | 285 | 1.13 | 0.0000156 | 3204 |
| Missense in Polyphen | 79 | 71.037 | 1.1121 | 872 | ||
| Synonymous | -0.545 | 128 | 120 | 1.06 | 0.00000800 | 943 |
| Loss of Function | 0.551 | 23 | 26.0 | 0.884 | 0.00000124 | 298 |
LoF frequencies by population
| Ethnicity | Sum of pLOFs | p |
|---|---|---|
| African & African-American | 0.00383 | 0.00384 |
| Ashkenazi Jewish | 0.00229 | 0.00228 |
| East Asian | 0.000870 | 0.000870 |
| Finnish | 0.0000924 | 0.0000924 |
| European (Non-Finnish) | 0.000308 | 0.000308 |
| Middle Eastern | 0.000870 | 0.000870 |
| South Asian | 0.000654 | 0.000523 |
| Other | 0.000326 | 0.000326 |
dbNSFP
Source:
- Function
- FUNCTION: The cytotoxic action of BPI is limited to many species of Gram-negative bacteria; this specificity may be explained by a strong affinity of the very basic N-terminal half for the negatively charged lipopolysaccharides that are unique to the Gram-negative bacterial outer envelope. Has antibacterial activity against the Gram-negative bacterium P.aeruginosa, this activity is inhibited by LPS from P.aeruginosa. {ECO:0000269|PubMed:1937776, ECO:0000269|PubMed:2722846}.;
- Pathway
- Neutrophil degranulation;Toll-Like Receptors Cascades;Antimicrobial peptides;Innate Immune System;Immune System;Toll Like Receptor 4 (TLR4) Cascade
(Consensus)
Recessive Scores
- pRec
- 0.125
Intolerance Scores
- loftool
- 0.940
- rvis_EVS
- 2.6
- rvis_percentile_EVS
- 98.77
Haploinsufficiency Scores
- pHI
- 0.283
- hipred
- N
- hipred_score
- 0.112
- ghis
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.0505
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | High |
| Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Bpi
- Phenotype
Gene ontology
- Biological process
- antimicrobial humoral response;negative regulation of interleukin-6 production;negative regulation of interleukin-8 production;negative regulation of tumor necrosis factor production;negative regulation of macrophage activation;neutrophil degranulation;defense response to Gram-negative bacterium
- Cellular component
- extracellular region;membrane;azurophil granule lumen;specific granule lumen;extracellular exosome
- Molecular function
- lipopolysaccharide binding